Dr. Mukherjee is the current Cardiac Director of the Aortic Institute at Yale New-Haven Hospital, a senior Editor of the journal AORTA, and on the Editorial Committee of The Medical Letter. He was former medical resident, chief medical resident, and cardiovascular fellow at Yale. He has served as a primary investigator in more than 20 clinical trials and has been a contributing editor for UpToDate, an author of several book chapters and has received several honors at Yale including the Betsy R. Harris Award, the Betsy Winters House Staff Award, the Hugh L Dwyer Award, and the Stephen R. Shell Award. He was a former Vice President of the South Asian Society of Atherosclerosis and Thrombosis and Associate Clinical Professor of Medicine at Yale.
With interests in consultative cardiology, preventive cardiology, diseases of the aorta, clinical research, and echocardiography, he has been recognized as "Top Doc" by Connecticut Magazine in years 2010, 2011, 2012, and 2013. Dr. Mukherjee is a Pearson Fellow at Yale University.
- Cardiovascular Diseases
- Coronary Disease
- Myocardial Infarction
Accepts new patients? Yes
Patient Type: Adult
Referrals: From patients or physicians
Patient Care Organizations
Cardiovascular Disease AB of Internal Medicine (1996)
|A Phase 3 double-blind, randomized, placebo-controlled, parallel-group study to assess the efficacy, long-term safety and tolerability of PF-04950615 in subjects with primary hyperlipidemia or mixed dysplipidemia at risk of cardiovascular events (SPIRE LDL)|
|Orbit AF - Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II|
|A Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of AMR101 on Cardiovascular Health and Mortality in Hypertriglyceridemic Patients with Cardiovascular Disease or at High Risk for Cardiovascular Disease: REDUCE-IT (Reduction of Cardiovascular Events with EPA Intervention Trial)|